Biomind Labs Inc.
BMNDF
$0.02
-$0.08-84.20%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 87.00K | 92.50K | 113.00K | 63.80K | 100.90K |
| Depreciation & Amortization | -- | -- | 2.20K | 2.20K | 2.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 87.00K | 92.50K | 115.20K | 94.40K | 90.90K |
| Operating Income | -87.00K | -92.50K | -115.20K | -94.40K | -90.90K |
| Income Before Tax | -102.80K | -116.50K | -66.80K | 172.30K | -34.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -102.80K | -116.50K | -66.80K | 172.30K | -34.50K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -102.80K | -116.50K | -66.80K | 172.30K | -34.50K |
| EBIT | -87.00K | -92.50K | -115.20K | -94.40K | -90.90K |
| EBITDA | -87.00K | -92.50K | -113.00K | -92.20K | -88.60K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 77.57M | 77.57M | 77.57M | 77.57M | 74.47M |
| Average Diluted Shares Outstanding | 77.57M | 77.57M | 77.57M | 77.57M | 74.47M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |